Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 11:20:1893-1913.
doi: 10.2147/COPD.S518218. eCollection 2025.

COTE and Pulmonary Comorbidities Predict Moderate-to-Severe Acute Exacerbation and Hospitalization in COPD

Qinglin Chen #  1 , Xinmao Wang #  1 , Xiujuan Yao  1 , Luo Zhang  2   3   4 , Xiaofang Liu  1
Affiliations

COTE and Pulmonary Comorbidities Predict Moderate-to-Severe Acute Exacerbation and Hospitalization in COPD

Qinglin Chen et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Purpose: The aim of this study was to explore the predictive value of the chronic obstructive pulmonary disease (COPD) specific comorbidity test index (COTE) and pulmonary comorbidities for moderate-to-severe acute exacerbation and hospitalization in COPD patients.

Patients and methods: This was a retrospective cohort study. We included 470 patients with stable COPD. Patients were divided into high or low-risk comorbidity group according to whether COTE score ≥4, and pulmonary comorbidities and extrapulmonary comorbidities group according to comorbidity origin. Moderate-to-severe acute exacerbation events and other clinical parameters were compared between groups. Multifactorial analysis and Lasso regression were used to screen risk factors and establish predictive models for moderate-to-severe acute exacerbation and hospitalization. The receiver operating characteristic (ROC) curve was used to assess the value COTE score and pulmonary comorbidities in predicting moderate-to-severe acute exacerbation and hospitalization.

Results: When compared with the low-risk comorbidity and extrapulmonary comorbidities group, the rate of patients with ≥2 moderate-to-severe acute exacerbations and requiring hospitalization due to acute exacerbations is higher in high-risk comorbidity and pulmonary comorbidities group (χ²=18.45, χ²=40.15, χ²=8.82, χ²=23.68). Multifactorial analysis showed that comorbid with asthma, lung cancer were risk factors for moderate-to-severe acute exacerbations, while asthma, bronchiectasis, lung cancer, and high COTE score were risk factors for patients requiring hospitalization due to acute exacerbations. The AUC for COTE > 5.5 and a combination of at least one pulmonary comorbidity as potential indication of moderate-to-severe acute exacerbations of COPD and hospitalization due to acute exacerbations was 0.667 (95% CI: 0.615, 0.719) and 0.740 (95% CI: 0.688, 0.792), respectively. The prediction models including COTE and pulmonary comorbidities can predict moderate-to-severe acute exacerbations (internal validation of AUC: 0.984, 95CI%: 0.964-1) and hospitalization (internal validation of AUC: 0.978, 95CI%: 0.959-0.998) of COPD.

Conclusion: COTE score and a combination of at least one pulmonary disease can predict the risk of moderate-to-severe acute exacerbations and hospitalization due to acute exacerbations in patients with COPD.

Keywords: acute exacerbation; chronic obstructive; comorbidity; hospitalization; pulmonary disease.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flow of participants through the study.
Figure 2
Figure 2
Correlation heatmap of COTE.
Figure 3
Figure 3
Logistic analysis of moderate-to-severe acute exacerbation and hospitalization of COPD.
Figure 4
Figure 4
ROC curve of moderate-to-severe acute exacerbation and hospitalization of COPD.
Figure 5
Figure 5
Prediction model of ROC curve of moderate-to-severe acute exacerbation in COPD.
Figure 6
Figure 6
Prediction model of ROC curve of hospitalization in COPD.
Figure 7
Figure 7
Nomogram to predict the risk of moderate-to-severe acute exacerbation in COPD. Lung_cancer/asthma (1: with; 2: without).
Figure 8
Figure 8
Nomogram to predict the risk of hospitalization in COPD. Lung_cancer/asthma/bronchiectasis (1: with; 2: without).
Figure 9
Figure 9
Impact of age subgroup to COTE and the number of pulmorbidome in moderate-to-severe acute exacerbation and hospitalization of COPD.
See this image and copyright information in PMC

References

    1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2024 report [EB/OL]. (2023-11-13)[2024-12-18]. Available from: https://goldcopd.org/2024-gold-report/. Accesssed June 03, 2025.
    1. Momtazmanesh S, Moghaddam SS, Ghamari S-H, GBD 2019 Chronic Respiratory Diseases Collaborators. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the global burden of disease study 2019. EClinicalMedicine. 2023;59:101936. doi: 10.1016/j.eclinm.2023.101936 - DOI - PMC - PubMed
    1. WHO. Multimorbidity. Geneva: world health organization. 2016. Available from: http://apps.who.int/iris/handle/10665/252275. Accessed 2003 June 11.
    1. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155–161. doi: 10.1164/rccm.201201-0034OC - DOI - PubMed
    1. Calverley PMA, Walker PP. Contemporary concise review 2022: chronic obstructive pulmonary disease. Respirology. 2023;28:428–436. doi: 10.1111/resp.14489 - DOI - PubMed

MeSH terms

LinkOut - more resources